Rchr
J-GLOBAL ID:201801007274162638   Update date: Sep. 24, 2024

Ohnuma Kei

Ohnuma Kei
Affiliation and department:
Homepage URL  (1): https://www.juntendo.ac.jp/graduate/laboratory/labo/immunity_cancer/
Research field  (6): Fetal medicine/Pediatrics ,  Hematology and oncology ,  Allergies and connective tissue disease ,  Immunology ,  Tumor biology ,  Molecular biology
Research theme for competitive and other funds  (13):
  • 2020 - 2023 ヒト免疫特有の炎症性因子IL-26に基づく慢性炎症病態の解明と新規治療法の開発
  • 2018 - 2021 Scientific research on development of anti-fibrotic agent targeting multi-organ profibrotic factor IL-26 in GVHD
  • 2016 - 2020 Prevention of chronic GVHD onset by HMGB1 inhibiton of DPP4
  • 2016 - 2019 Molecular understanding of CD26-mediated immune regulatory mechanism and development of novel molecular targeted therapy for the treatment of refractory autoimmune diseases
  • 2015 - 2018 Mechanism of lung fibrosis in chronic GVHD
Show all
Papers (120):
  • Shun Sato, Takeshi Kawasaki, Ryo Hatano, Yu Koyanagi, Yukiko Takahashi, Kei Ohnuma, Chikao Morimoto, Steven M Dudek, Koichiro Tatsumi, Takuji Suzuki. Functional roles of CD26/DPP4 in lipopolysaccharide-induced lung injury. American journal of physiology. Lung cellular and molecular physiology. 2024
  • Ryo Hatano, Takumi Itoh, Haruna Otsuka, Harumi Saeki, Ayako Yamamoto, Dan Song, Yuki Shirakawa, Satoshi Iyama, Tsutomu Sato, Noriaki Iwao, et al. Humanized anti-IL -26 monoclonal antibody as a novel targeted therapy for chronic graft-versus-host disease. American Journal of Transplantation. 2022
  • Eriko Komiya, Mitsutoshi Tominaga, Ryo Hatano, Yuji Kamikubo, Sumika Toyama, Hakushun Sakairi, Kotaro Honda, Takumi Itoh, Yayoi Kamata, Munehiro Tsurumachi, et al. Peripheral endomorphins drive mechanical alloknesis under the enzymatic control of CD26/DPPIV. Journal of Allergy and Clinical Immunology. 2021. 149. 3. 1085-1096
  • Takumi Itoh, Ryo Hatano, Yoshiya Horimoto, Taketo Yamada, Dan Song, Haruna Otsuka, Yuki Shirakawa, Shuji Mastuoka, Noriaki Iwao, Thomas M. Aune, et al. IL-26 mediates epidermal growth factor receptor-tyrosine kinase inhibitor resistance through endoplasmic reticulum stress signaling pathway in triple-negative breast cancer cells. Cell Death & Disease. 2021. 12. 6. 520-520
  • Yutaro Kaneko, Ryo Hatano, Naoto Hirota, Nicolas Isambert, Véronique Trillet-Lenoir, Benoit You, Jérôme Alexandre, Gérard Zalcman, Fanny Valleix, Thomas Podoll, et al. Serum soluble CD26/DPP4 titer variation is a potential prognostic biomarker in cancer therapy with a humanized anti-CD26 antibody. Biomarker Research. 2021. 9. 1. 21-21
more...
MISC (51):
Patents (11):
  • 抗CD26抗体と免疫チェックポイント阻害剤との併用療法
  • 抗癌剤への抵抗改善剤
  • 抗癌剤への抵抗性改善剤
  • 免疫チェックポイント阻害剤
  • 森本幾夫 大沼圭 波多野良 伊藤匠
more...
Books (10):
  • Advanced in Medicine and Biology
    Nova Science Publishers Inc 2019
  • Advances in Medicine and Biology
    Nova Science Publishers Inc 2018
  • Horizons in Cancer Research
    Nova Science Publishers Inc 2017
  • 小児処方ノート
    中外医学社 2001 ISBN:4498045831
  • 小児処方ノート
    中外医学社 2001 ISBN:4498045831
more...
Lectures and oral presentations  (46):
  • Possible regulation of mechanical itch by CD26/DPPIV
    (10th World Congress on Itch (WCI) 2019)
  • Possible role for CD26/DPPIV in regulating mechanical itch (Alloknesis)
    (28th European Academy of Dermatology and Venereology (EADV) Congress 2019)
  • CD26/DPPIV regulates mechanical itch by enzymatic degradation of mu-opioid receptor ligands
    (24th World Congress of Dermatology (WCD) 2019)
  • Interleukin-26-targeted therapy for the control of chronic GVHD
    (2018)
  • 乾癬における新規炎症性サイトカインIL-26の役割と分子標的療法の開発
    (第33回 日本乾癬学会学術大会 2018)
more...
Professional career (1):
  • 博士(医学) (東京大学大学院)
Committee career (2):
  • 日本リウマチ学会 評議員
  • 日本血液学会 評議員
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page